World
Bambusa Therapeutics Initiates First Clinical Trial for BBT001 a Bispecific Antibody Targeting Atopic Dermatitis
Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopi...
March 03, 2025 | News
WuXi Biologics Passes Japan’s PMDA GMP Inspection for Wuxi Drug Substance Facilities
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has...
February 28, 2025 | News
Metabolon Expands Multiomics Biomarker Discovery with New Integrated Bioinformatics Capabilities
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic dev...
February 28, 2025 | News
Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine
The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical...
February 27, 2025 | News
MicuRx’s MRX-4 and Contezolid Show Favorable Safety and Efficacy in Phase III Trial for Diabetic Foot Infections
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued pro...
February 26, 2025 | News
HBM Alpha Therapeutics Secures $395M Licensing Deal to Advance CRH-Targeting Therapy
HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaborati...
February 26, 2025 | News
Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business for $4.1 Billion in Cash
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that the company has en...
February 25, 2025 | News
Biological E. Partners with Bavarian Nordic to Manufacture Chikungunya Vaccine for LMICs in Asia, Africa, and Latin America
The manufacturing agreement is the first step in working together to provide Chikungunya Vaccine to low-and middle-income countries The initial t...
February 25, 2025 | News
SK Bioscience Advances mRNA Vaccine for Japanese Encephalitis with Phase 1/2 Trials in Australia and New Zealand
SK bioscience’s first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026. ...
February 25, 2025 | News
MGI Partners with Oncoclínicas&Co to Expand Genomic Testing and Oncology Diagnostics in Brazil
MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, established a partnersh...
February 25, 2025 | News
AIM Vaccine Accelerates Global Expansion with FDA Submissions for mRNA Shingles and RSV Vaccines
As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in China is in full swi...
February 25, 2025 | News
Australia Grants First Global Market Approval for YORVIPATH® to Treat Chronic Hypoparathyroidism
YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism...
February 21, 2025 | News
CKGSB and Johns Hopkins Launch AI-Driven Healthcare Innovation Program for Senior Leaders
The Cheung Kong Graduate School of Business (CKGSB) and Johns Hopkins University's Carey Business School are proud to announce the launch of...
February 20, 2025 | News
Ascletis’ ASC30 Oral Tablet Shows Promising Weight Loss in U.S. Phase Ib Obesity Trial
- ASC30 oral once-daily tablet demonstrated a 6.3% mean body weight reduction from baseline after 28-day treatment in multiple ascendi...
February 20, 2025 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
